Artelo Biosciences, Inc.
ARTL
$7.16
-$0.15-2.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.27% | -175.62% | -32.39% | 4.47% | -22.94% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 850.00% | 137.66% | 28.23% | 73.91% | 183.87% |
| Change in Net Operating Assets | -147.15% | -513.50% | 913.82% | 200.17% | 149.40% |
| Cash from Operations | -13.40% | -349.61% | 75.08% | 45.72% | 1.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.40% | -105.88% | -- | -- | -81.76% |
| Cash from Investing | -62.40% | -105.88% | -- | -- | -81.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,987.72% | -- | -- | -- | 78.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,719.30% | -- | -- | -- | 78.13% |
| Foreign Exchange rate Adjustments | 55.56% | -1,150.00% | 1,900.00% | 350.00% | -800.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.53% | -109.95% | 520.38% | 1.73% | -1,247.16% |